Call Directions Website Contact the business

Carterra High-throughput discovery and characterization technology Carterra, Inc. For additional information, please visit www.carterra-bio.com.

Carterraยฎ is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra's high throughput LSA, LSAXT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented microfluidics technology with real-time High-Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading analysis and visualization software. These systems deliver up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing label-free platforms. The LSAXT and Ultra instruments introduce enhancements to Carterraโ€™s flagship product, the LSA, increasing sensitivity and enabling new applications in biotherapeutic discovery and small molecule analysis. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity.

Congratulations to Dr. Kathryn Hastie on her appointment as Research Assistant Professor at La Jolla Institute for Immun...
10/13/2026

Congratulations to Dr. Kathryn Hastie on her appointment as Research Assistant Professor at La Jolla Institute for Immunology (LJI)! ๐ŸŽ‰

Building on her groundbreaking work in structural virology and antibody discovery, Dr. Hastie is launching her own lab to tackle emerging viral threats and advance the development of broadly protective antibody therapies. We're excited to see what comes next and wish Kathryn and her team continued success!

Read more about her work and this exciting new chapter: https://www.lji.org/news-events/news/post/kathryn-hastie-research-assistant-professor/

At ๐—˜๐—Ÿ๐—ฅ๐—œ๐—š ๐——๐—ฟ๐˜‚๐—ด ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, Carterra's Dan Bedinger, PhD, will explore how HT-SPR has become the gold-standard data en...
10/13/2026

At ๐—˜๐—Ÿ๐—ฅ๐—œ๐—š ๐——๐—ฟ๐˜‚๐—ด ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, Carterra's Dan Bedinger, PhD, will explore how HT-SPR has become the gold-standard data engine for AI-driven drug design at biopharma, generating high-throughput kinetic data for model training and Lab-in-the-Loop workflows. Don't miss his talk on October 14th!

Find us at ๐—ฆ๐˜๐—ฎ๐—ป๐—ฑ ๐—š๐Ÿฌ๐Ÿด to learn more.

๐—ฆ๐—บ๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐˜† ๐˜€๐—ฒ๐—น๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป, ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—ฑ๐—ฎ๐˜๐—ฎ! At ๐—™๐—ฒ๐˜€๐˜๐—ถ๐˜ƒ๐—ฎ๐—น ๐—ผ๐—ณ ๐—•๐—ถ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐˜€ ๐—•๐—ฎ๐˜€๐—ฒ๐—น, Tobin Brown of Mosaic Biosciences will shar...
10/09/2026

๐—ฆ๐—บ๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐˜† ๐˜€๐—ฒ๐—น๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป, ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—ฑ๐—ฎ๐˜๐—ฎ!

At ๐—™๐—ฒ๐˜€๐˜๐—ถ๐˜ƒ๐—ฎ๐—น ๐—ผ๐—ณ ๐—•๐—ถ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐˜€ ๐—•๐—ฎ๐˜€๐—ฒ๐—น, Tobin Brown of Mosaic Biosciences will share findings from a study comparing three selection strategies that achieved similar outcomes in affinity, epitope coverage, and developability, enabled by Carterra's HT-SPRโ„ข technology.

Mosaic will also present ๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ #๐Ÿญ๐Ÿฏ๐Ÿณ, showcasing the humanization of 22 mouse antibodies and kinetic characterization of 104 antibodies and variants in a single Carterra LSA-XT instrument run!

Catch Tobin's talk in ๐—ง๐—ต๐—ฒ๐—ฎ๐˜๐—ฟ๐—ฒ ๐Ÿฑ and visit Poster #137!

Next week, Carterraโ€™s VP of Product, Christopher Silva will join ACROBiosystemsโ€™ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐——๐—ฎ๐˜† ๐˜… ๐—”๐—œ to dig into one of ...
10/08/2026

Next week, Carterraโ€™s VP of Product, Christopher Silva will join ACROBiosystemsโ€™ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐——๐—ฎ๐˜† ๐˜… ๐—”๐—œ to dig into one of the biggest opportunities in AI-driven drug discovery: ๐—ฐ๐—น๐—ผ๐˜€๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—น๐—ผ๐—ผ๐—ฝ ๐—ฏ๐—ฒ๐˜๐˜„๐—ฒ๐—ฒ๐—ป ๐—ฐ๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ฝ๐—ฟ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐˜ƒ๐—ฎ๐—น๐—ถ๐—ฑ๐—ฎ๐˜๐—ถ๐—ผ๐—ป.

Chris will share perspectives on how high-throughput, data-rich experimentation can help feed better models, accelerate iteration, and move promising predictions toward real biological insight.

Register today for this exclusive event and join the conversation! https://luma.com/0gbshi5x

Join Carterraโ€™s Daniel Bedinger, PhD, at Sino Biologicalโ€™s ๐—”๐—œ-๐—ฃ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐—ป ๐—ฃ๐—ฟ๐—ผ๐˜๐—ฒ๐—ถ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—”๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐˜† ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€ (๐—”...
09/29/2026

Join Carterraโ€™s Daniel Bedinger, PhD, at Sino Biologicalโ€™s ๐—”๐—œ-๐—ฃ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐—ป ๐—ฃ๐—ฟ๐—ผ๐˜๐—ฒ๐—ถ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—”๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐˜† ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€ (๐—”๐—œ๐—ฃ๐—”๐—ง) ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ on October 2 in Cambridge, MA, as he explores how HT-SPR technology has become the gold standard ๐˜๐—ฟ๐—ฎ๐—ถ๐—ป๐—ถ๐—ป๐—ด-๐—ฑ๐—ฎ๐˜๐—ฎ ๐—ฒ๐—ป๐—ด๐—ถ๐—ป๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—”๐—œ-๐—ด๐˜‚๐—ถ๐—ฑ๐—ฒ๐—ฑ ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฑ๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜†โ€”from Lab-in-the-Loop antibody discovery to small molecule drug discovery.

Seats are running outโ€”register today: https://www.biolinkevents.com/aipat

See how Carterra Ultraยฎ combines sensitivity and speed for antibody binding kinetics and epitope binningโ€”including ๐Ÿต๐Ÿฒ ร— ...
09/24/2026

See how Carterra Ultraยฎ combines sensitivity and speed for antibody binding kinetics and epitope binningโ€”including ๐Ÿต๐Ÿฒ ร— ๐Ÿต๐Ÿฒ ๐—ฏ๐—ถ๐—ป๐—ป๐—ถ๐—ป๐—ด ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ถ๐—ป ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐Ÿฎ๐Ÿฐ ๐—ต๐—ผ๐˜‚๐—ฟ๐˜€.

Explore the data and download the application note: https://carterra-bio.com/resources/carterra-ultras-high-sensitivity-and-speed-benefit-antibody-binding-kinetics-and-epitope-binning-analysis/

The ๐—”๐—œntibody Challenge brought together 29 organizations to put computational antibody design to the testโ€”not just on a...
09/23/2026

The ๐—”๐—œntibody Challenge brought together 29 organizations to put computational antibody design to the testโ€”not just on a screen, but through prospective, blinded experimental validation.

Weโ€™re excited to see Carterraโ€™s Daniel Bedinger among the authors of this ๐˜•๐˜ข๐˜ต๐˜ถ๐˜ณ๐˜ฆ ๐˜‰๐˜ช๐˜ฐ๐˜ต๐˜ฆ๐˜ค๐˜ฉ๐˜ฏ๐˜ฐ๐˜ญ๐˜ฐ๐˜จ๐˜บ study, with Carterraโ€™s HT-SPR technology and binding data being the standard to evaluate antibody kinetics and affinity.

Read the full article here: https://carterra-bio.com/resources/a-blinded-prospective-benchmark-of-in-silico-antibody-discovery-anchored-to-experimental-affinity-and-developability/

Weโ€™re pleased to announce that Tim Germann, ๐—–๐—ต๐—ถ๐—ฒ๐—ณ ๐—–๐—ผ๐—บ๐—บ๐—ฒ๐—ฟ๐—ฐ๐—ถ๐—ฎ๐—น ๐—ข๐—ณ๐—ณ๐—ถ๐—ฐ๐—ฒ๐—ฟ ๐—ฎ๐˜ ๐—–๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ๐—ฟ๐—ฎ, will join Novoptimโ€™s 20th anniversary ...
09/21/2026

Weโ€™re pleased to announce that Tim Germann, ๐—–๐—ต๐—ถ๐—ฒ๐—ณ ๐—–๐—ผ๐—บ๐—บ๐—ฒ๐—ฟ๐—ฐ๐—ถ๐—ฎ๐—น ๐—ข๐—ณ๐—ณ๐—ถ๐—ฐ๐—ฒ๐—ฟ ๐—ฎ๐˜ ๐—–๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ๐—ฟ๐—ฎ, will join Novoptimโ€™s 20th anniversary event in Paris as a panelist for ๐—ง๐˜„๐—ฒ๐—ป๐˜๐˜† ๐—ฌ๐—ฒ๐—ฎ๐—ฟ๐˜€ ๐—ผ๐—ณ ๐—Ÿ๐—ถ๐—ณ๐—ฒ ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—–๐—ผ๐—บ๐—บ๐—ฒ๐—ฟ๐—ฐ๐—ถ๐—ฎ๐—น๐—ถ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป.

Tim will share his perspective on what it takes to successfully bring new technologies to market in the era of AI Drug Discovery.

๐Ÿ“… September 24, 2026
๐Ÿ“ Paris, France
๐Ÿ‘‰ Secure your seat: https://lnkd.in/evsJcmW8

Weโ€™re heading to Boston for Discovery on Target! Join Carterraโ€™s Dr. Daniel Bedinger at his talk to explore how high-qua...
09/18/2026

Weโ€™re heading to Boston for Discovery on Target!

Join Carterraโ€™s Dr. Daniel Bedinger at his talk to explore how high-quality, ๐—ต๐—ถ๐—ด๐—ต-๐˜๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต๐—ฝ๐˜‚๐˜ ๐—ฆ๐—ฃ๐—ฅ binding data is powering ๐—”๐—œ-๐—ด๐˜‚๐—ถ๐—ฑ๐—ฒ๐—ฑ ๐—ฑ๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† and ๐—Ÿ๐—ฎ๐—ฏ-๐—ถ๐—ป-๐˜๐—ต๐—ฒ-๐—Ÿ๐—ผ๐—ผ๐—ฝ ๐˜„๐—ผ๐—ฟ๐—ธ๐—ณ๐—น๐—ผ๐˜„๐˜€.

And donโ€™t miss our posters showcasing HT-SPR in actionโ€”from large-scale characterization of drug candidates against ๐˜๐—ฟ๐—ฎ๐—ป๐˜€๐—บ๐—ฒ๐—บ๐—ฏ๐—ฟ๐—ฎ๐—ป๐—ฒ ๐—ฟ๐—ฒ๐—ฐ๐—ฒ๐—ฝ๐˜๐—ผ๐—ฟ๐˜€ to ๐—ณ๐—ฟ๐—ฎ๐—ด๐—บ๐—ฒ๐—ป๐˜ ๐˜€๐—ฐ๐—ฟ๐—ฒ๐—ฒ๐—ป๐—ถ๐—ป๐—ด, including a comparison of experimental SPR results with AI binding predictions.

See us at Booth 406 | Sept. 28โ€“Oct. 1
Dr. Dan Bedingerโ€™s talk - Sept. 30th at 3:35 pm

Anthropicโ€™s ground breaking AI drug discovery study developing binders for 15 targets brings autonomous AI protein desig...
09/11/2026

Anthropicโ€™s ground breaking AI drug discovery study developing binders for 15 targets brings autonomous AI protein design into the wet labโ€”where experimental data evaluates AI-generated designs.

Twist Bioscience and Adaptyv Bio helped make that wet-lab validation possible with Carterraโ€™s HT-SPR technology binding affinity data. A great example of how AI and gold-standard HT-SPR are coming together to reshape protein discovery.

Read the latest here: https://carterra-bio.com/news/carterra-enables-anthropics-autonomous-ai-protein-design-study-via-its-ht-spr-binding-platforms/

Address

825 N. 300 W, Suite C309
Salt Lake City, UT
84103

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 9am - 6pm

Telephone

+18446427635

Alerts

Be the first to know and let us send you an email when Carterra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Carterra:

Shortcuts

Share